Keywords: AstraZeneca, MedImmune, FluMist, Quadrivalent, Flu vaccine, USA, FDA, Bayer, Angeliq, Menopasue

FDA OKs first quadrivalent flu vaccine; and lower dose Angeliq

Article | 01 March 2012

Anglo-Swedish drug major AstraZeneca (LSE: AZN) US unit MedImmune’s FluMist Quadrivalent, a vaccine to prevent seasonal influenza in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in